参考文献
[1] Gupta T, Goel K, Kolte D, et al. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement[J]. JACC Cardiovasc Interv, 2017,10(20):2050-2060. DOI: 10.1016/j.jcin.2017.07.044.
[2] Chikwe J, Castillo JG, Rahmanian PB, et al. The impact of moderate-to-end-stage renal failure on outcomes after coronary artery bypass graft surgery[J]. J Cardiothorac Vasc Anesth, 2010,24(4):574-579. DOI: 10.1053/j.jvca.2009.10.017.
[3] 徐灿, 周庆, 潘俊, 等. 透析依赖患者行心脏手术的围手术期管理和手术时机选择[J].中华胸心血管外科杂志,2017,33(11):681-682,688. DOI: 10.3760/cma.j.issn.1001-4497.2017.11.009.
Can X, Qing Z, Jun P, et al.Perioperative management of patients undergoing cardiac surgery and the timing of surgery in dialysis patients[J].Chin J Thorac Cardiovasc Surg,2017,33(11):681-682,688. DOI: 10.3760/cma.j.issn.1001-4497.2017.11.009.
[4] Gajdos C, Hawn MT, Kile D, et al. The risk of major elective vascular surgical procedures in patients with end-stage renal disease[J]. Ann Surg, 2013,257(4):766-773. DOI: 10.1097/SLA.0b013e3182686b87.
[5] Cavanaugh PK, Chen AF, Rasouli MR, et al. Complications and Mortality in Chronic Renal Failure Patients Undergoing Total Joint Arthroplasty: A Comparison Between Dialysis and Renal Transplant Patients[J]. J Arthroplasty, 2016,31(2):465-472. DOI: 10.1016/j.arth.2015.09.003.
[6] Gajdos C, Hawn MT, Kile D, et al. Risk of major nonemergent inpatient general surgical procedures in patients on long-term dialysis[J]. JAMA Surg, 2013,148(2):137-143. DOI: 10.1001/2013.jamasurg.347.
[7] Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery[J]. Circulation, 2016,134(10):e123-155. DOI: 10.1161/CIR.0000000000000404.
[8] Herzog CA, Shroff GR. Atherosclerotic versus nonatherosclerotic evaluation: the Yin and Yang of cardiovascular imaging in advanced chronic kidney disease[J]. JACC Cardiovasc Imaging, 2014,7(7):729-732. DOI: 10.1016/j.jcmg.2013.12.016.
[9] Weber M, Luchner A, Seeberger M, et al. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery[J]. Eur Heart J, 2013,34(11):853-862. DOI: 10.1093/eurheartj/ehs445.
[10] Fahim MA, Hayen A, Horvath AR, et al. N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients[J]. Clin J Am Soc Nephrol, 2015,10(4):620-629. DOI: 10.2215/CJN.09060914.
[11] Pianta TJ, Horvath AR, Ellis VM, et al. Cardiac high-sensitivity troponin T measurement: a layer of complexity in managing haemodialysis patients[J]. Nephrology (Carlton), 2012,17(7):636-641. DOI: 10.1111/j.1440-1797.2012.01625.x.
[12] 中国医院协会血液净化中心分会血管通路工作组. 中国血液透析用血管通路专家共识(第2版)[J].中国血液净化,2019,18(6):365-381. DOI: 10.3969/j.issn.1671-4091.2019.06.001.
Chinese Journal of Blood Purification,2019,18(6):365-381. DOI: 10.3969/j.issn.1671-4091.2019.06.001.
[13] Georgianos PI, Sarafidis PA, Sinha AD, et al. Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals?[J]. Am J Nephrol, 2015,41(4-5):400-408. DOI: 10.1159/000435842.
[14] Brunelli SM, Du Mond C, Oestreicher N, et al. Serum Potassium and Short-term Clinical Outcomes Among Hemodialysis Patients: Impact of the Long Interdialytic Interval[J]. Am J Kidney Dis, 2017,70(1):21-29. DOI: 10.1053/j.ajkd.2016.10.024.
[15] Pani A, Floris M, Rosner MH, et al. Hyperkalemia in hemodialysis patients[J]. Semin Dial, 2014,27(6):571-576. DOI: 10.1111/sdi.12272.
[16] Nemati E, Taheri S. Electrocardiographic manifestations of hyperkalemia in hemodialysis patients[J]. Saudi J Kidney Dis Transpl, 2010,21(3):471-477.
[17] Weisberg LS. The risk of preoperative hyperkalemia[J]. Semin Dial, 2003,16(1):78-79. DOI: 10.1046/j.1525-139x.2003.03017_2.x.
[18] Renew JR, Pai SL. A simple protocol to improve safety and reduce cost in hemodialysis patients undergoing elective surgery[J]. Middle East J Anaesthesiol, 2014,22(5):487-492.
[19] Agarwal R, Nissenson AR, Batlle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States[J]. Am J Med, 2003,115(4):291-297. DOI: 10.1016/s0002-9343(03)00366-8.
[20] Agarwal R, Flynn J, Pogue V, et al. Assessment and management of hypertension in patients on dialysis[J]. J Am Soc Nephrol, 2014,25(8):1630-1646. DOI: 10.1681/ASN.2013060601.
[21] Howell SJ, Sear JW, Fo?x P. Hypertension, hypertensive heart disease and perioperative cardiac risk[J]. Br J Anaesth, 2004,92(4):570-583. DOI: 10.1093/bja/aeh091.
[22] Yancey R. Anesthetic Management of the Hypertensive Patient: Part II[J]. Anesth Prog, 2018,65(3):206-213. DOI: 10.2344/anpr-65-03-17.
[23] K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients[J]. Am J Kidney Dis, 2005,45(4 Suppl 3):S1-153.
[24] 中国医师协会肾脏病医师分会血液透析充分性协作组. 中国血液透析充分性临床实践指南[J].中华医学杂志,2015,95(34):2748-2753. DOI: 10.3760/cma.j.issn.0376-2491.2015.34.004.
@@[J].Natl Med J China,2015,95(34):2748-2753. DOI: 10.3760/cma.j.issn.0376-2491.2015.34.004.
[25] Hollmann C, Fernandes NL, Biccard BM. A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery[J]. Anesth Analg, 2018,127(3):678-687. DOI: 10.1213/ANE.0000000000002837.
[26] 中华医学会肾脏病学分会肾性贫血诊断和治疗共识专家组. 肾性贫血诊断与治疗中国专家共识(2018修订版)[J].中华肾脏病杂志,2018,34(11):860-866. DOI: 10.3760/cma.j.issn.1001?7097.2018.11.012.
Chin J Neahrol,2018,34(11):860-866. DOI: 10.3760/cma.j.issn.1001?7097.2018.11.012.
[27] Bahrainwala J, Berns JS. Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease[J]. Semin Nephrol, 2016,36(2):94-98. DOI: 10.1016/j.semnephrol.2016.02.002.
[28] Holden RM, Harman GJ, Wang M, et al. Major bleeding in hemodialysis patients[J]. Clin J Am Soc Nephrol, 2008,3(1):105-110. DOI: 10.2215/CJN.01810407.
[29] Acedillo RR, Shah M, Devereaux PJ, et al. The risk of perioperative bleeding in patients with chronic kidney disease: a systematic review and meta-analysis[J]. Ann Surg, 2013,258(6):901-913. DOI: 10.1097/SLA.0000000000000244.
[30] Hedges SJ, Dehoney SB, Hooper JS, et al. Evidence-based treatment recommendations for uremic bleeding[J]. Nat Clin Pract Nephrol, 2007,3(3):138-153. DOI: 10.1038/ncpneph0421.
[31] Pawlak K, Mysliwiec M, Pawlak D. Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients[J]. Thromb Haemost, 2009,102(1):49-55. DOI: 10.1160/TH08-10-0696.
[32] 仇冰梅, 孙磊, 张晓华, 等. 术前伴有严重肾功能不全的患者围术期管理经验[J].中国体外循环杂志,2016,14(4):229-232. DOI: 10.13498/j.cnki.chin.j.ecc.2016.04.10.
Bing-mei Q, Lei S, Xiao-hua Z, et al.Perioperative treatment for cardiac surgical patients with severe renal insuffi-ciency[J].2016,14(4):229-232. DOI: 10.13498/j.cnki.chin.j.ecc.2016.04.10.
[33] 师恩档, 谷天祥, 喻磊. 肾功能不全患者心脏手术的围术期管理[J].实用医学杂志,2010,26(1):83-85. DOI: 10.3969/j.issn.1006-5725.2010.01.038.
En-yi S, Tian-xiang GU, Lei YU.Perioperative period treatment for patients with renal dysfunction underwent cardiac surgery[J].THE JOURNAL OF PRACTICAL MEDICINE,2010,26(1):83-85. DOI: 10.3969/j.issn.1006-5725.2010.01.038.
[34] 吕佳璇, 李月红. 局部枸橼酸抗凝在连续性肾脏替代治疗中的应用[J].临床内科杂志,2017,34(4):230-232. DOI: 10.3969/j.issn.1001-9057.2017.04.004.
Journal of Clinical Internal Medicine,2017,34(4):230-232. DOI: 10.3969/j.issn.1001-9057.2017.04.004.
[35] Obi Y, Rhee CM, Mathew AT, et al. Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients[J]. J Am Soc Nephrol, 2016,27(12):3758-3768. DOI: 10.1681/ASN.2015101142.
[36] Mathew AT, Fishbane S, Obi Y, et al. Preservation of residual kidney function in hemodialysis patients: reviving an old concept[J]. Kidney Int, 2016,90(2):262-271. DOI: 10.1016/j.kint.2016.02.037.
[37] Serpa NA, Veelo DP, Peireira VG, et al. Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature[J]. J Crit Care, 2014,29(1):185.e1-7. DOI: 10.1016/j.jcrc.2013.09.031.
